Nrf2 in adipocytes.
- Published in:
- Archives of Pharmacal Research, 2020, v. 43, n. 3, p. 350, doi. 10.1007/s12272-020-01227-0
- By:
- Publication type:
- Article
Works matching IS 02536269 AND DT 2020 AND VI 43 AND IP 3
Results: 7
1
2
NRF2-driven redox metabolism takes center stage in cancer metabolism from an outside-in perspective.
- Published in:
- Archives of Pharmacal Research, 2020, v. 43, n. 3, p. 321, doi. 10.1007/s12272-020-01224-3
- By:
- Publication type:
- Article
3
Cis-element architecture of Nrf2–sMaf heterodimer binding sites and its relation to diseases.
- Published in:
- Archives of Pharmacal Research, 2020, v. 43, n. 3, p. 275, doi. 10.1007/s12272-019-01193-2
- By:
- Publication type:
- Article
4
Nrf2 in liver toxicology.
- Published in:
- Archives of Pharmacal Research, 2020, v. 43, n. 3, p. 337, doi. 10.1007/s12272-019-01192-3
- By:
- Publication type:
- Article
5
Emerging evidence for crosstalk between Nrf2 and mitochondria in physiological homeostasis and in heart disease.
- Published in:
- Archives of Pharmacal Research, 2020, v. 43, n. 3, p. 286, doi. 10.1007/s12272-019-01188-z
- By:
- Publication type:
- Article
6
Mitochondrial biology in airway pathogenesis and the role of NRF2.
- Published in:
- Archives of Pharmacal Research, 2020, v. 43, n. 3, p. 297, doi. 10.1007/s12272-019-01182-5
- By:
- Publication type:
- Article
7
Filtering through the role of NRF2 in kidney disease.
- Published in:
- Archives of Pharmacal Research, 2020, v. 43, n. 3, p. 361, doi. 10.1007/s12272-019-01177-2
- By:
- Publication type:
- Article